Literature DB >> 7989125

Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.

R B Veenhuizen1, M C Ruevekamp-Helmers, T J Helmerhorst, P Kenemans, W J Mooi, J P Marijnissen, F A Stewart.   

Abstract

Toxicity studies for intraperitoneal photodynamic therapy (IPPDT) were performed in Wag/RijA rats, using specially designed light delivery blocks for proper light distribution and light dosimetry. A recently developed photosensitizer mesotetrahydroxyphenylchlorin (mTHPC), excited at 652-nm wave-length, was compared with Photofrin (630 nm). Toxicity profiles for various sensitizer doses, light fluences and time intervals were investigated. A light fluence of 15 J.cm-2 delivered to the entire peritoneum 24 hr after 5 mg Photofrin per kg i.v. induced reversible impairment of intestinal, liver and kidney function. A dose of 0.2 mg mTHPC per kg i.v. followed by 6 J.cm-2 at 72 hr appeared to be equitoxic to the intestines; however, functional tests revealed little effect for this mTHPC-mediated IPPDT regime on liver or kidney. Histology demonstrated focal irreversible damage to the kidneys for both photosensitizers, not reflected in functional impairment. Light doses of 25 to 30 J.cm-2 at 24 hr after Photofrin or 8-12 J.cm-2, 72 hr after mTHPC caused lethal toxicity in the first 2 weeks due to intestinal damage. Higher light doses caused a shock syndrome and rhabdomyolysis resulting in death within 20 hr for both photosensitizers. In conclusion, maximum tolerable schedules for whole-abdomen IPPDT were defined for Photofrin and mTHPC. Both photosensitizers caused similar toxicity profiles depending on drug dose, light fluence and time interval.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989125     DOI: 10.1002/ijc.2910590620

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release.

Authors:  Dandan Luo; Kevin A Carter; Aida Razi; Jumin Geng; Shuai Shao; Daniel Giraldo; Ulas Sunar; Joaquin Ortega; Jonathan F Lovell
Journal:  Biomaterials       Date:  2015-10-23       Impact factor: 12.479

2.  Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes.

Authors:  Kevin A Carter; Sophie Wang; Jumin Geng; Dandan Luo; Shuai Shao; Jonathan F Lovell
Journal:  Mol Pharm       Date:  2015-12-31       Impact factor: 4.939

3.  Rapid Light-Triggered Drug Release in Liposomes Containing Small Amounts of Unsaturated and Porphyrin-Phospholipids.

Authors:  Dandan Luo; Nasi Li; Kevin A Carter; Cuiyan Lin; Jumin Geng; Shuai Shao; Wei-Chiao Huang; Yueling Qin; G Ekin Atilla-Gokcumen; Jonathan F Lovell
Journal:  Small       Date:  2016-04-28       Impact factor: 13.281

4.  Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer.

Authors:  L R Duska; M R Hamblin; M P Bamberg; T Hasan
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Minimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.

Authors:  R Hornung; M K Fehr; J Monti-Frayne; B J Tromberg; M W Berns; Y Tadir
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

6.  Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.

Authors:  H B Ris; T Krueger; A Giger; C K Lim; J C Stewart; U Althaus; H J Altermatt
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model.

Authors:  A Obwegeser; R Jakober; H Kostron
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

8.  Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

Authors:  R B Veenhuizen; J P Marijnissen; P Kenemans; M C Ruevekamp-Helmers; L W 't Mannetje; T J Helmerhorst; F A Stewart
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.